Roth Capital Lowers Earnings Estimates for Ayr Wellness

Ayr Wellness Inc. (OTCMKTS:AYRWF) – Equities research analysts at Roth Capital cut their FY2024 EPS estimates for shares of Ayr Wellness in a research note issued to investors on Wednesday, November 13th. Roth Capital analyst W. Kirk now forecasts that the company will earn ($1.40) per share for the year, down from their prior estimate of ($1.22). Roth Capital currently has a “Strong-Buy” rating on the stock. The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.30) per share. Roth Capital also issued estimates for Ayr Wellness’ Q4 2024 earnings at ($0.34) EPS, Q1 2025 earnings at ($0.32) EPS, Q2 2025 earnings at ($0.31) EPS, Q3 2025 earnings at ($0.30) EPS, Q4 2025 earnings at ($0.30) EPS and FY2025 earnings at ($1.23) EPS.

Other equities analysts have also recently issued reports about the company. Roth Mkm reduced their price objective on Ayr Wellness from $3.50 to $3.00 and set a “buy” rating on the stock in a research note on Thursday, November 14th. Atb Cap Markets lowered shares of Ayr Wellness from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 13th.

Ayr Wellness Trading Down 6.5 %

Shares of OTCMKTS AYRWF opened at $0.72 on Monday. The stock has a market capitalization of $82.19 million, a P/E ratio of -0.32 and a beta of 2.00. The stock’s 50 day moving average price is $1.77 and its two-hundred day moving average price is $1.96. The company has a quick ratio of 0.58, a current ratio of 1.59 and a debt-to-equity ratio of 0.76. Ayr Wellness has a 52-week low of $0.71 and a 52-week high of $4.09.

About Ayr Wellness

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.